RUNX1 and neoplasm: Consequently, the N-t and RD truncates, like RUNX1 can perhaps take part in pathways, such as FOXO in the absence of TGF-β, while in the presence of TGF-β, beside FOXO pathway, can play a weaker role in tumor-promoter arm of TGF-β.